Michal Kielbik Selected Research

1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazene

10/2016	Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines.
1/2015	Antitumoral Activity Of Nitric Oxide-Releasing Compounds.
11/2014	Nitric oxide donors reduce the invasion ability of ovarian cancer cells in vitro.
11/2013	Nitric oxide donors: spermine/NO and diethylenetriamine/NO induce ovarian cancer cell death and affect STAT3 and AKT signaling proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michal Kielbik Research Topics

Disease

12	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2012
10	Neoplasms (Cancer) 01/2022 - 01/2012
5	Infections 01/2019 - 01/2013
2	Ovarian Epithelial Carcinoma 09/2020 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2014
1	Ascites 12/2021
1	Necrosis 12/2020
1	Breast Neoplasms (Breast Cancer) 09/2020
1	Tuberculosis (Tuberculoses) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 04/2018

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
4	CytokinesIBA 12/2021 - 01/2017
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 11/2014
4	1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA 10/2016 - 11/2013
3	Nitric Oxide DonorsIBA 10/2016 - 11/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2019
2	AntigensIBA 01/2022 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2021
2	Cadherins (E-Cadherin)IBA 01/2021 - 09/2020
2	Interleukin-2 (IL2)IBA 12/2020 - 01/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 11/2014
2	Biological ProductsIBA 01/2017 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 02/2013
2	spermine nitric oxide complexIBA 10/2016 - 01/2015
2	SpermineIBA 11/2014 - 11/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013 - 01/2013
1	Interleukin-6 (Interleukin 6)IBA 12/2021
1	CalreticulinIBA 11/2021
1	ChemokinesIBA 11/2021
1	Interleukin-12 (IL 12)IBA 12/2020
1	InterferonsIBA 12/2020
1	InterleukinsIBA 12/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2020
1	Formaldehyde (Formol)FDA Link 09/2020
1	ParaffinIBA 09/2020
1	MicroRNAs (MicroRNA)IBA 09/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 04/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 10/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2015
1	Cytostatic AgentsIBA 01/2015
1	Metalloproteases (Metalloproteinases)IBA 11/2014
1	Matrix Metalloproteinases (MMPs)IBA 11/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014
1	CholesterolIBA 02/2013
1	ImmunosorbentsIBA 02/2013
1	EnzymesIBA 02/2013
1	CarbonIBA 02/2013

Therapy/Procedure

6	Therapeutics 12/2021 - 11/2014
1	Drug Therapy (Chemotherapy) 12/2021
1	Photochemotherapy (Photodynamic Therapy) 11/2021
1	Radiotherapy 11/2021